Delivery Order SPE2DB22D9367-SPE2DB25FSY59

Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $18,488.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S medication. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,488.12 contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 award is for the delivery of the pharmaceutical product TRIKAFTA 100-50-75 MG/150 MG UU 84S. This is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA to provide a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,488.12 contract is for the delivery of TRIKAFTA 100-50-75 MG/150 MG with a completion date of June 13, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $18,526.83 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of TRIKAFTA 100-50-75 MG/150 MG tablets to support the medical supply needs of military facilities. This delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Vehicle (IDV) contract SPE2DB with DLA, valued at up to $4,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,053.68 firm fixed-price delivery order contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG medication to support the recurring medical needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant $499,999,999 single-award indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the pharmaceutical product TRIKAFTA 80-40-60MG/59.5MG PKT 14S, with a period of performance through July 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $18,488.12 contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG UU 84S, a pharmaceutical product, with a completion date of June 9, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $73,952.48 firm fixed-price contract is for the delivery of TRIKAFTA 100-50-75 MG/150 MG medical supplies. The contract has an ultimate completion date of May 6, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $37,053.68 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is under the SPE2DB program, a multi-year indefinite delivery vehicle DMS Pharmaceutical Group holds with DLA valued at up to $4,999,999 for a broad range of pharmaceutical products. This order is for TRIKAFTA, a prescription medication, with an ultimate completion date of April 3,...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB25FSY59
    Delivery Order

This is a $18,474.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract provides TRIKAFTA 50-25-37.5 MG/75 MG UU 84S medication to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery orders for a comprehensive range of pharmaceutical products. This positioning establishes DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The contract does not have a set-aside designation.

Generated 9/22/25, 9:48 AM